Health
Antimalarial drug shows in vitro activity against SARS-CoV-2 and flu viruses – News-Medical.Net
Now, a new study published in the preprint server bioRxiv in July 2020 reports on the antiviral activity of two drugs found in an antimalarial drug currently in phase II trials in South Korea, called Pyramax.
The COVID-19 pandemic has taken a massive toll on human life, with the virus spreading to 188 countries and territories and infecting nearly 17 million individuals. A very significant source of uncertainty in dealing with the pandemic has been the lack of any effective antiviral or vaccine against the causative agent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) despite strenuous scientific efforts.
Now, a new study published in the preprint server bioRxiv* in July 2020 reports o…
-
General23 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News22 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland
-
Noosa News21 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News23 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland